By Ashley Blacker In Prostate CancerPosted 29/09/2016Immediate hormones in men with positive lymph nodes after radical prostatectomy is associated with a progression free survival benefit of 14 years versus 2.4 years if just watched and better overall and prostate cancer specific survival at 12 years READ MORE
By Ashley Blacker In Prostate CancerPosted 29/09/2016Zoledronic acid 4 mg infusion every 3 weeks in men with bone metastases in hormone resistant prostate cancer and normal kidney function have 11% fewer skeletal complications including fewer fractures, a longer time to any skeletal problem and less pain READ MORE
By Ashley Blacker In Prostate CancerPosted 29/09/2016Denosumab delays time to bone metastasis in patients with hormone refractory non-metastatic prostate cancer who are at high risk of bone metastasis READ MORE
By Ashley Blacker In Prostate CancerPosted 29/09/2016Docetaxel plus prednisone has superior overall survival, PSA response, pain and quality of life response versus mitoxantrone in metastatic hormone refractory prostate cancer READ MORE
By Ashley Blacker In Prostate CancerPosted 29/09/2016Abiraterone plus prednisone prolongs overall survival in metastatic hormone resistant prostate cancer in men who have already had docetaxel chemotherapy READ MORE
By Ashley Blacker In Prostate CancerPosted 29/09/2016Extended lymph node dissection should be performed as part of surgery for high and intermediate risk prostate cancer READ MORE
By Ashley Blacker In Prostate CancerPosted 29/09/2016Active surveillance is a good strategy for men with clinically insignificant prostate cancer who want to preserve their erectile and urinary function until definitive treatment is needed READ MORE
By Ashley Blacker In Prostate CancerPosted 29/09/2016Men with Gleason 5-6 prostate cancer followed for 24 years and treated conservatively have a very low risk of dying from prostate cancer whereas men with Gleason 7-10 are likely to die from prostate cancer READ MORE
By Ashley Blacker In Prostate CancerPosted 29/09/201670 Gy radiotherapy to the prostate, seminal vesicles and whole pelvis when combined with 3 years of hormones improves overall and disease specific survival compared with radiotherapy on its own READ MORE
By Ashley Blacker In Prostate CancerPosted 29/09/2016High risk prostate cancer requires multi-modality treatment however surgery can be offered with good results READ MORE
